Fazal Hadi | Pharmaceutical Sciences | Best Researcher Award

Dr. Fazal Hadi | Pharmaceautical sciences | Best Researcher Award

Dr. Fazal Hadi, Abdul Wali Khan University Mardan, Pakistan

Dr. Fazal Hadi is a dedicated hospital pharmacist and emerging researcher from Mardan, Pakistan. Currently pursuing his PhD in Pharmaceutical Sciences at AWKUM, he specializes in pharmacology, phytochemistry, and drug interaction studies. With hands-on experience as a pharmacist at MERF hospitals and academic roles as a visiting lecturer and research assistant, Dr. Hadi blends practical expertise with academic excellence. He has authored multiple publications in reputed journals and actively participates in scientific conferences. Fluent in Pashto, Urdu, and English, he is passionate about improving patient care through innovative pharmaceutical research.

Publication Profile

Orcid

Google Scholar

🧪 Professional Experience

Dr. Fazal Hadi brings extensive pharmaceutical and academic experience to his role in healthcare and research. As a Visiting Lecturer at AWKUM (2025–present), he engages students with lectures and guides scholarly work. From 2022–2024, he worked as a Research Assistant, mastering techniques like PCR, RNA extraction, and in vivo assays. Concurrently, he served as a Pharmacist at MERF hospitals in Peshawar, ensuring drug stock management and patient care. Earlier roles include service at a COVID-19 hospital and GIK Institute. His leadership as Pharmacy Store In-Charge during the “Sihat ka Insaaf” campaign in 2015 further highlights his dedication.

🎓 Educational Background

Dr. Fazal Hadi has pursued a progressive academic journey in pharmaceutical sciences. He is currently enrolled in a Ph.D. in Pharmaceutical Sciences at AWKUM, Mardan (2026, in progress) 🧪. He completed his MPhil in Pharmacology from Abasyn University, Peshawar in 2019 with a CGPA of 3.27/4 📊. He earned his Doctor of Pharmacy (Pharm D) from Gandhara University, Peshawar in 2014 with First Division 💊. Additionally, he holds a Bachelor of Arts in Sociology from AWKUM (2011) and completed FSc (Pre-medical) at Islamia College, Peshawar (2008, A+ grade) and Matriculation in Science in 2006 with an A1+ grade

🔬 Research Focus

Dr. Fazal Hadi’s research primarily revolves around pharmacology, ethnopharmacology, and natural product chemistry 🌿. His work emphasizes the therapeutic potential of medicinal plants, focusing on their analgesic, antipyretic, anthelmintic, antidiabetic, and nutritional properties 🌱🧬. He also investigates food–drug interactions, as shown in his pharmacokinetics research on grape juice and omeprazole 🥤💊. His studies bridge traditional medicine with modern pharmacological validation, contributing to safe and effective drug discovery. By integrating in vivo, in vitro, and molecular techniques, his research supports innovation in herbal medicine, clinical pharmacy, and pharmaceutical sciences

Publication Top Notes

📄 “Integrating In Vitro, Network Pharmacology, and Molecular Docking Approaches to Uncover the Antidiabetic Potential of Tylophora hirsutaComputational Biology and Chemistry, 2025 
📄 “Unveiling the Therapeutic and Nutritious Potential of Vigna unguiculata in Line with its Phytochemistry”Heliyon, 2024 | Cited by: 10 🌱🧬
📄 Vigna mungo (Linn.) Hepper: Ethnobotanical, Pharmacological, Phytochemical, and Nutritious Profile”Phytochemistry Reviews, 2024 | Cited by: 1 🌿📚
📄 “In Vivo Investigations of Analgesic, Antipyretic and Anthelmintic Activities of Various Extracts of Fernandoa adenophyllaPharmaceutical Chemistry Journal, 2021 | Cited by: 4 🧫💊
📄 “Impact of Fresh Grape Juice on the Pharmacokinetics of Omeprazole: Results of a Food–Drug Interaction Study”Frontiers in Pharmacology, 2024

Lingyang Zhang | Toxicology | Best Researcher Award

Dr. Lingyang Zhang | Toxicology | Best Researcher Award

Henan Academy of Sciences, China

Publication Profile

Scopus

 

Strengths for the Award

  1. Educational Background: Lingyang Zhang has a solid academic foundation, with a Bachelor’s and Master’s degree from Hunan University of Science and Technology and a Doctorate from Nankai University. This diverse educational experience reflects a strong commitment to advancing knowledge.
  2. Significant Publications: Zhang has contributed to high-impact research in notable journals such as Angewandte Chemie International Edition, ACS Applied Materials & Interfaces, and Analytica Chimica Acta. The focus on innovative areas like nanodrugs, protein couplings, and carbon dots highlights his expertise in cutting-edge research.
  3. Awards and Recognitions: The Bronze Award at the 2nd National Postdoctoral Innovation and Entrepreneurship Competition and selection for the Outstanding Postdoctoral Leadership Program in Henan Province demonstrate recognition of Zhang’s contributions and leadership in the field.
  4. Diverse Research Interests: His work spans various applications, including tumor therapy, protein interactions, and cellular imaging, showcasing a broad and impactful research portfolio.

Areas for Improvement

  1. Citation and Impact Metrics: Providing citation counts and impact factors for his publications would offer a clearer picture of the influence and reach of Zhang’s work. This quantitative data can be crucial in assessing the broader impact of his research.
  2. Broader Collaboration: Expanding collaborations with international research institutions could enhance the visibility and impact of his work. While his research is impressive, interdisciplinary and global collaborations often amplify a researcher’s influence.
  3. Research Diversity: While Zhang has a strong focus on specific areas, incorporating research into emerging or interdisciplinary fields could broaden his impact and showcase adaptability to new scientific challenges.

Conclusion

Lingyang Zhang is a highly qualified candidate for the “Research for Best Researcher Award.” His educational background, significant publications in reputable journals, and recognition through prestigious awards highlight his expertise and contributions to his field. By enhancing the visibility of his work through impact metrics and expanding research collaborations, Zhang could further strengthen his candidacy. Overall, his achievements and ongoing contributions make him a strong contender for the award.

 

 

Education

🎓 Zhang earned his Doctorate in Science from Nankai University (2016-2022) after completing his Master’s (2013-2016) and Bachelor’s (2013-2016) degrees at Hunan University of Science and Technology.

Experience

🔬 Zhang has been actively involved in cutting-edge research, focusing on the development of novel nanodrugs and advanced imaging techniques. His work includes efficient protein–protein couplings and ratiometric fluorescence imaging.

Research Focus

🔍 Zhang’s research centers on nanotechnology applications in tumor therapy, fluorescence imaging with carbon dots, and the development of innovative detection methods for biological markers.

Awards

🏅 Zhang has received the Bronze Award at the 2nd National Postdoctoral Innovation and Entrepreneurship Competition in China and was selected for the Outstanding Postdoctoral Leadership Program in Henan Province.

Publications

  1. Junling An, Zequn Zhang, Jinrui Zhang, Lingyang Zhang*, Gaofeng Liang*, Research progress in tumor therapy of carrier-free nanodrug, Biomedicine & Pharmacotherapy, 2024, 178, 117258.
  2. XunCheng Su*, LingYang Zhang, LiNa Zhao, BinBin Pan, BenGuang Chen, JiaLiang Chen, ChengLiang Zhai, and Bin Li. Efficient protein–protein couplings mediated by small molecules under mild conditions, Angewandte Chemie International Edition, 2022, 61, e202205597.
  3. Lingyang Zhang, Donghui Wang, Haowen Huang*, Lanfang Liu, Yuan Zhou, Xiaodong Xia, Keqin Deng, and Xuanyong Liu*. Preparation of gold−carbon dots and ratiometric fluorescence cellular imaging, ACS Applied Materials & Interfaces, 2016, 8, 6646−6655.
  4. Lingyang Zhang, Shenna Chen, Qian Zhao, Haowen Huang *, Carbon dots as a fluorescent probe for label-free detection of physiological potassium level in human serum and red blood cells, Analytica Chimica Acta, 2015, 880, 130–135.